Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Prev Post 5 Biggest Blockchain ETFs in 2025 June 4, 2025 Next Post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case June 4, 2025 Related Posts Can You Invest in Neuralink? February 4, 2026 Westport Announces $6.5 Million Milestone Payment From Light-Duty Divestiture February 4, 2026 Osisko Metals Closes C$15 Million “Bought-Deal” Flow-Through Share Financing February 4, 2026